All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional.

The Lupus Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

The Lupus Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Lupus Hub cannot guarantee the accuracy of translated content. The Lupus Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.

Steering CommitteeAbout UsNewsletterContact

James Cheng-Chung WeiSteering Committee Member

James Cheng-Chung Wei is Professor of Institute of Medicine, Chung Shan Medical University and Vice Superintendent and Director of the Clinical Trial Center of Chung Shan Medical University Hospital, Taichung, TW.  

After his training in rheumatology and clinical immunology at Taichung and Kaohsiung Veterans General Hospital, Professor Wei undertook a fellowship at the Royal National Hospital for Rheumatic Diseases, Bath, UK, under Professor Andrei Calin. He pursued a research fellowship at the University of California, Los Angeles, US, under Professor David Yu, investigating the pathogenesis of spondylarthritis.   

He has published 400+ articles in SCI journals, such as the NEJM, JAMA, Lancet, Annals of the Rheumatic Diseases, Arthritis & Rheumatology, International Journal of Epidemiology, and Rheumatology. He had been the principal investigator of more than 150 global clinical trials and PI-initiated studies. He is currently the Editor-in-Chief of the International Journal of Rheumatic Diseases and Associate Editor of Frontiers in Immunology and Frontiers in Pharmacology.  

His major interests are translational research in ankylosing spondylitis, clinical trials and big data epidemiological studies.